SYK
Stryker Corporation · Healthcare · Medical - Devices
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2026
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | 0 | 438.61K | $109.42M | n/a | −1 |
| Q2 2026 | 170 | +2 | 220.81M | $69.86B | +7 | −6 |
| Q1 2026 | 172 | -2 | 215.42M | $70.87B | +1 | −4 |
| Q4 2025 | 173 | -1 | 229.53M | $80.67B | +1 | −1 |
| Q3 2025 | 25 | +3 | 142.80M | $52.79B | +4 | −2 |
| Q2 2025 | 20 | 0 | 117.11M | $46.33B | +1 | −1 |
| Q1 2025 | 17 | -2 | 51.08M | $19.01B | n/a | −2 |
| Q4 2024 | 19 | 0 | 52.07M | $18.75B | +1 | −1 |
| Q3 2024 | 18 | +2 | 39.19M | $14.15B | +2 | n/a |
| Q2 2024 | 16 | n/a | 41.27M | $14.03B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | TD Waterhouse Canada Inc. | 208.61K | -1.0% | $57.00M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 2 | Wealth Enhancement Advisory… | 162.54K | +20.4% | $33.84M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 3 | Ninety One UK Ltd | 45.10K | -3.8% | $12.42M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Assenagon Asset Management S.A. | 22.36K | -71.1% | $6.16M | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Robeco Institutional Asset… | $100.27M | was 0.1% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 2,274 holders, 283.44M shares, $87.41B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
Director · 18 sh @ 225.19 · $4,054
Director · 3 sh @ 185.65 · $557
Director · 36 sh @ 193.21 · $6,956
Director · 11 sh @ 221.03 · $2,431
Director · 63 sh @ 202.21 · $12,739
Open-market sales (S)
Officer · 441 sh · $144,915
Director · 11.26K sh · $3.81M
Director · 40 sh · $13,272
Director · 440 sh · $146,598
Director · 200 sh · $66,786
Director · 80 sh · $26,804
Director · 320 sh · $107,774
Director · 2.31K sh · $780,062
Director · 10.81K sh · $3.67M
Director · 16.61K sh · $5.66M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology